1. Home
  2. PALT vs NERV Comparison

PALT vs NERV Comparison

Compare PALT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PALT
  • NERV
  • Stock Information
  • Founded
  • PALT 1998
  • NERV 2007
  • Country
  • PALT United States
  • NERV United States
  • Employees
  • PALT 17
  • NERV N/A
  • Industry
  • PALT EDP Services
  • NERV Biotechnology: Pharmaceutical Preparations
  • Sector
  • PALT Technology
  • NERV Health Care
  • Exchange
  • PALT Nasdaq
  • NERV Nasdaq
  • Market Cap
  • PALT 16.1M
  • NERV 18.3M
  • IPO Year
  • PALT N/A
  • NERV 2014
  • Fundamental
  • Price
  • PALT $1.87
  • NERV $2.19
  • Analyst Decision
  • PALT Hold
  • NERV Hold
  • Analyst Count
  • PALT 1
  • NERV 1
  • Target Price
  • PALT N/A
  • NERV $5.00
  • AVG Volume (30 Days)
  • PALT 45.0K
  • NERV 25.4K
  • Earning Date
  • PALT 11-12-2024
  • NERV 11-05-2024
  • Dividend Yield
  • PALT N/A
  • NERV N/A
  • EPS Growth
  • PALT N/A
  • NERV N/A
  • EPS
  • PALT N/A
  • NERV N/A
  • Revenue
  • PALT $9,635,475.00
  • NERV N/A
  • Revenue This Year
  • PALT N/A
  • NERV N/A
  • Revenue Next Year
  • PALT $3.52
  • NERV N/A
  • P/E Ratio
  • PALT N/A
  • NERV N/A
  • Revenue Growth
  • PALT N/A
  • NERV N/A
  • 52 Week Low
  • PALT $1.67
  • NERV $2.07
  • 52 Week High
  • PALT $5.50
  • NERV $13.49
  • Technical
  • Relative Strength Index (RSI)
  • PALT 36.66
  • NERV 41.39
  • Support Level
  • PALT $1.68
  • NERV $2.08
  • Resistance Level
  • PALT $1.94
  • NERV $2.35
  • Average True Range (ATR)
  • PALT 0.17
  • NERV 0.10
  • MACD
  • PALT 0.03
  • NERV -0.00
  • Stochastic Oscillator
  • PALT 21.63
  • NERV 40.92

About PALT Paltalk Inc.

Paltalk Inc is a communications software innovator. It operates a network of consumer applications where users can meet, see, chat, broadcast and message in real-time in a secure environment with others in the network. The company's product portfolio includes Paltalk, Camfrog, Tinychat and Vumber. Its consumer applications generate revenue principally from subscription fees and advertising arrangements. The company's majority revenue is generated from live video chat products that are :Paltalk and Camfrog.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: